Hint mode is switched on Switch off
For swift navigation between sections

Organization: Gilead Sciences
LEI 549300WTZWR07K8MNV44, SWIFT GILSUS6SXXX

Organization name
Gilead Sciences Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
25,250 mln USD

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Latest data on

Profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and serious cardiovascular and respiratory conditions.

Awards

Documentation

Stocks

Latest issues

Bond debt by currency

Codes

  • LEI
    549300WTZWR07K8MNV44
  • SWIFT
    GILSUS6SXXX
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • CIK
    0000882095

Credit ratings

Macroeconomic Indicators - Gilead Sciences

Registration is required to get access.